What is the dosage adjustment for Co-amoxyclav (amoxicillin/clavulanate) in patients with mild impaired renal function (creatinine level of 1.2)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 1, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Co-amoxiclav Dosing with Creatinine 1.2 mg/dL

No dosage adjustment is required for co-amoxiclav (amoxicillin/clavulanate) when serum creatinine is 1.2 mg/dL, as this represents mild renal impairment with creatinine clearance typically >30 mL/min. 1

Assessment of Renal Function

  • A serum creatinine of 1.2 mg/dL does not automatically indicate significant renal impairment, as creatinine clearance provides a more accurate assessment than serum creatinine alone 2
  • Calculate creatinine clearance using the Cockcroft-Gault equation to determine the actual degree of renal function, as patients can have significantly decreased glomerular filtration rates despite near-normal creatinine levels 2
  • For most patients with creatinine 1.2 mg/dL, the calculated creatinine clearance will exceed 50 mL/min, placing them in the normal to mild impairment category 1

Standard Dosing Recommendations

Standard dosing regimens (typically 500/125 mg three times daily or 875/125 mg twice daily) can be used for patients with creatinine clearance >30 mL/min. 1

  • The Infectious Diseases Society of America supports standard dosing for normal to mild renal impairment 1
  • Population pharmacokinetic studies in critically ill patients demonstrate that standard dosing regimens (1 g four times daily or 2 g three times daily intravenously) are appropriate for most patients except those with creatinine clearance >190 mL/min 3

When Dose Adjustment Becomes Necessary

Dosage modifications are only required when renal function deteriorates further:

  • Moderate to severe impairment (CrCl 10-30 mL/min): Reduce dosage by approximately 50% or double the dosing interval 1
  • End-stage renal disease (CrCl <10 mL/min): Reduce to 25-50% of normal dose 1
  • Hemodialysis patients: Administer dose after dialysis session to avoid premature drug removal 1

Monitoring Considerations

  • Patients with borderline renal function (creatinine 1.2-1.5 mg/dL) may benefit from 24-hour urine collection to accurately define the degree of impairment before making regimen changes 1
  • Close monitoring for adverse effects is warranted, as drug accumulation can occur with any degree of renal insufficiency 1
  • Serum creatinine alone underestimates renal impairment compared to calculated creatinine clearance, particularly in elderly patients and those with reduced muscle mass 2

Common Pitfalls to Avoid

  • Do not assume all antibiotics require the same degree of dosage adjustment in renal impairment—co-amoxiclav specifically requires adjustment only when CrCl falls below 30 mL/min 1, 4
  • Avoid relying solely on serum creatinine without calculating creatinine clearance, as this may miss clinically significant renal impairment 2
  • Do not prematurely reduce doses in patients with mild elevations in creatinine (1.2-1.5 mg/dL) without first confirming reduced creatinine clearance, as this may result in subtherapeutic drug levels 4

References

Guideline

Coamoxiclav Dosage Adjustments in Renal Impairment

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Estimated creatinine clearance instead of plasma creatinine level as prognostic test for postoperative renal function in patients undergoing coronary artery bypass surgery.

European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery, 2006

Guideline

Dosing Adjustments for Antibiotics in Renal Impairment

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Related Questions

What dose reduction is recommended for dextromethorphan and amoxicillin-clavulanate (Augmentin) in an elderly patient with stage 3b Chronic Kidney Disease (CKD)?
What is the recommended dose of Augmentin (amoxicillin/clavulanate) for a patient with impaired renal function, specifically a creatinine level of 2.04 and a glomerular filtration rate (GFR) of 33?
What is the recommended dosage adjustment for Augmentin (amoxicillin/clavulanate) in a patient with impaired renal function?
Is a 5-day lack of response from a urologist's office to a patient's concerns about a possible urinary tract infection (UTI), despite multiple attempts to contact them, considered patient abandonment, given the patient's history of kidney stones, sepsis, and recent hospital discharge for stent placement, and current symptoms including flank pain, low-grade fever, and positive test results for leukocytes and nitrites, while taking Augmentin (amoxicillin/clavulanate)?
What is the best course of action for a patient with a history of obstructing ureteral stone and infection, currently on Augmentin (amoxicillin/clavulanate), presenting with severe flank pain, signs of infection, impaired liver function, and anemia, 3 days after discharge following stent placement?
Is the Respiratory Syncytial Virus (RSV) vaccine a live vaccine?
Should Eliquis (apixaban) be given as treatment or prophylaxis for an acute mesenteric embolic event?
What is the best course of treatment for an elderly male patient with urosepsis, mild to moderate left hydronephrosis, impaired renal function, and diabetes, who is voiding on his own but with uncertain bladder emptying?
Why are face masks not used for patients with pulmonary (pulmo) bronchiectasis?
What vaccines should be administered to a patient prior to starting infliximab (chimeric monoclonal antibody against tumor necrosis factor-alpha)?
What is the recommended treatment approach for a patient with Chronic Obstructive Pulmonary Disease (COPD) using Long-Acting Muscarinic Antagonist (LAMA) therapy?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.